thanks for some sobering position
$BNGO Know what you own. Market Cap: $203M. Sales: $7.3M Income: -$37M. #SaphyrGenomeMapping Just a blink of an eyelid ago, this stock was in danger of getting delisted. Now, they've been granted a 180-day extension for Nasdaq listing compliance. The company says they will use a reverse stock split strategy if necessary. Roth Capital has a $0.75 price target on the stock, expressing concern about the current cash burn rate. Oppenheimer has a price target of $1.50.
View original message